{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:39:47Z","timestamp":1784990387316,"version":"3.55.0"},"reference-count":61,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.1248\/bpb.b25-00399","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:09:24Z","timestamp":1772662164000},"page":"438-451","source":"Crossref","is-referenced-by-count":1,"title":["The Differences in Gut Microbiota Due to Dietary Habits Affect the Onset of Disease Pathology in a Dextran Sulfate Sodium-Induced Colitis Model"],"prefix":"10.1248","volume":"49","author":[{"given":"Chiho","family":"Takahara","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama, Hiroshima 729\u20130292, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Tabuchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama, Hiroshima 729\u20130292, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama, Hiroshima 729\u20130292, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honoka","family":"Itoh","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Showa Medical University, 1\u20135\u20138 Hatanodai, Shinagawa-ku, Tokyo 142\u20138555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Koike","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Showa Medical University, 1\u20135\u20138 Hatanodai, Shinagawa-ku, Tokyo 142\u20138555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Showa Medical University, 1\u20135\u20138 Hatanodai, Shinagawa-ku, Tokyo 142\u20138555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Takayama","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama, Hiroshima 729\u20130292, Japan"},{"name":"School of Pharmacy, Showa Medical University, 1\u20135\u20138 Hatanodai, Shinagawa-ku, Tokyo 142\u20138555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA<\/i>, 330<\/b>, 951\u2013965 (2023).","DOI":"10.1001\/jama.2023.15389"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Calvi\u00f1o-Su\u00e1rez C, Ferreiro-Iglesias R, Bast\u00f3n-Rey I, Barreiro-de Acosta M. Role of quality of life as endpoint for inflammatory bowel disease treatment. Int. J. Environ. Res. Public Health<\/i>, 18<\/b>, 7159 (2021).","DOI":"10.3390\/ijerph18137159"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Okabayashi S, Kobayashi T, Hibi T. Inflammatory bowel disease in Japan-is it similar to or different from westerns? J. Anus Rectum Colon<\/i>, 4<\/b>, 1\u201313 (2020).","DOI":"10.23922\/jarc.2019-003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol. Rep.<\/i>, 63<\/b>, 629\u2013642 (2011).","DOI":"10.1016\/S1734-1140(11)70575-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des. Devel. Ther.<\/i>, 5<\/b>, 185\u2013210 (2011).","DOI":"10.2147\/DDDT.S11290"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology<\/i>, 152<\/b>, 313\u2013321.e2 (2017).","DOI":"10.1053\/j.gastro.2016.10.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol.<\/i>, 18<\/b>, 56\u201366 (2021).","DOI":"10.1038\/s41575-020-00360-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol.<\/i>, 2<\/b>, 187\u2013196 (2009).","DOI":"10.1038\/mi.2009.8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity<\/i>, 34<\/b>, 293\u2013302 (2011).","DOI":"10.1016\/j.immuni.2011.03.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Palm NW, De Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell<\/i>, 158<\/b>, 1000\u20131010 (2014).","DOI":"10.1016\/j.cell.2014.08.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol.<\/i>, 13<\/b>, R79 (2012).","DOI":"10.1186\/gb-2012-13-9-r79"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs<\/i>, 72<\/b>, 803\u2013823 (2012).","DOI":"10.2165\/11632710-000000000-00000"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kiesler P, Fuss IJ, Strober W. Experimental models of inflammatory bowel diseases. Cell. Mol. Gastroenterol. Hepatol.<\/i>, 1<\/b>, 154\u2013170 (2015).","DOI":"10.1016\/j.jcmgh.2015.01.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat. Protoc.<\/i>, 2<\/b>, 541\u2013546 (2007).","DOI":"10.1038\/nprot.2007.41"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takayama K, Takahara C, Tabuchi N, Okamura N. Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation. Sci. Rep.<\/i>, 9<\/b>, 3833 (2019).","DOI":"10.1038\/s41598-019-40278-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fujita N, Oritani K, Ichii M, Yokota T, Saitoh N, Okuzaki D, Sekine Y, Kon S, Muromoto R, Saitoh K, Yoshimura A, Matsuda T, Kanakura Y. Signal-transducing adaptor protein-2 regulates macrophage migration into inflammatory sites during dextran sodium sulfate induced colitis. Eur. J. Immunol.<\/i>, 44<\/b>, 1791\u20131801 (2014).","DOI":"10.1002\/eji.201344239"},{"key":"17","unstructured":"17) Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol.<\/i>, 37<\/b>, 852\u2013857 (2019)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J.<\/i>, 17<\/b>, 10\u201312 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods<\/i>, 13<\/b>, 581\u2013583 (2016).","DOI":"10.1038\/nmeth.3869"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Gl\u00f6ckner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res.<\/i>, 41<\/b> (<\/b>D1)<\/b>, D590\u2013D596 (2013).","DOI":"10.1093\/nar\/gks1219"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol.<\/i>, 12, R60<\/b> (<\/b>2011).","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Inoue H, Takayama K, Takahara C, Tabuchi N, Okamura N, Narahara N, Kojima E, Date Y, Tsuruta Y. Determination of short-chain fatty acids in mouse feces by high-performance liquid chromatography using 2-nitrophenylhydrazine as a labeling reagent. Biol. Pharm. Bull.<\/i>, 42<\/b>, 845\u2013849 (2019).","DOI":"10.1248\/bpb.b18-01017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Mamun MAA, Rakib A, Mandal M, Singh UP. Impact of a high-fat diet on the gut microbiome: a comprehensive study of microbial and metabolite shifts during obesity. Cells<\/i>, 14<\/b>, 463 (2025).","DOI":"10.3390\/cells14060463"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol.<\/i>, 2<\/b>, 285\u2013293 (2001).","DOI":"10.1038\/35067088"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat. Rev. Gastroenterol. Hepatol.<\/i>, 20<\/b>, 417\u2013432 (2023).","DOI":"10.1038\/s41575-023-00766-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kuo WT, Shen L, Zuo L, Shashikanth N, Ong MLDM, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase 3 expression. Gastroenterology<\/i>, 157<\/b>, 1323\u20131337 (2019).","DOI":"10.1053\/j.gastro.2019.07.058"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Xing T, Benderman LJ, Sabu S, Parker J, Yang J, Lu Q, Ding L, Chen YH. Tight junction protein Claudin-7 is essential for intestinal epithelial stem cell self-renewal and differentiation. Cell. Mol. Gastroenterol. Hepatol.<\/i>, 9<\/b>, 641\u2013659 (2020).","DOI":"10.1016\/j.jcmgh.2019.12.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr. Patterns<\/i>, 6<\/b>, 581\u2013588 (2006).","DOI":"10.1016\/j.modgep.2005.12.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J. Cell Biol.<\/i>, 141<\/b>, 199\u2013208 (1998).","DOI":"10.1083\/jcb.141.1.199"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol. Motil.<\/i>, 24<\/b>, 503\u2013512 (2012).","DOI":"10.1111\/j.1365-2982.2012.01921.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hu Y, Chen Z, Xu C, Kan S, Chen D. Disturbances of the gut microbiota and microbiota-derived metabolites in inflammatory bowel disease. Nutrients<\/i>, 14<\/b>, 5140 (2022).","DOI":"10.3390\/nu14235140"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Pittayanon R, Lau JT, Leontiadis GI, Tse F, Yuan Y, Surette M, Moayyedi P. Differences in gut microbiota in patients with vs<\/i>. without inflammatory bowel diseases: A systematic review. Gastroenterology<\/i>, 158<\/b>, 930\u2013946.e1 (2020).","DOI":"10.1053\/j.gastro.2019.11.294"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol.<\/i>, 11<\/b>, 7 (2011).","DOI":"10.1186\/1471-2180-11-7"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Corr\u00eaa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunology<\/i>, 5<\/b>, e73 (2016).","DOI":"10.1038\/cti.2016.17"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Parada Venegas D, De La Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol.<\/i>, 10<\/b>, 277 (2019).","DOI":"10.3389\/fimmu.2019.00277"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Zhou HC, Yu WW, Yan XY, Liang XQ, Ma XF, Long JP, Du XY, Mao HY, Liu HB. Lactate-driven macrophage polarization in the inflammatory microenvironment alleviates intestinal inflammation. Front. Immunol.<\/i>, 13<\/b>, 1013686 (2022).","DOI":"10.3389\/fimmu.2022.1013686"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cui L, Guan X, Ding W, Luo Y, Wang W, Bu W, Song J, Tan X, Sun E, Ning Q, Liu G, Jia X, Feng L. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int. J. Biol. Macromol.<\/i>, 166<\/b>, 1035\u20131045 (2021).","DOI":"10.1016\/j.ijbiomac.2020.10.259"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Arpaia N, Campbell C, Fan X, Dikiy S, Van Der Veeken J, Deroos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature<\/i>, 504<\/b>, 451\u2013455 (2013).","DOI":"10.1038\/nature12726"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol.<\/i>, 9<\/b>, 313\u2013323 (2009).","DOI":"10.1038\/nri2515"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology<\/i>, 160<\/b>, 524\u2013537 (2021).","DOI":"10.1053\/j.gastro.2020.09.056"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Jia L, Jiang Y, Wu L, Fu J, Du J, Luo Z, Guo L, Xu J, Liu Y. Porphyromonas gingivalis<\/i> aggravates colitis via<\/i> a gut microbiota-linoleic acid metabolism-Th17\/Treg cell balance axis. Nat. Commun.<\/i>, 15<\/b>, 1617 (2024).","DOI":"10.1038\/s41467-024-45473-y"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Eribo OA, du Plessis N, Chegou NN. The intestinal commensal, Bacteroides fragilis<\/i>, modulates host responses to viral infection and therapy: lessons for exploration during mycobacterium tuberculosis infection. Infect. Immun.<\/i>, 90<\/b>, e0032121 (2022).","DOI":"10.1128\/IAI.00321-21"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B, Shen C, Ma Y, Jiang S, Ma D, Tong T, Zhang X, Gao Z, Zhu X, Fang JY, Chen H, Hong J. Enterotoxigenic Bacteroides fragilis<\/i> promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p. Gastroenterology<\/i>, 161<\/b>, 1552\u20131566.e12 (2021).","DOI":"10.1053\/j.gastro.2021.08.003"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature<\/i>, 441<\/b>, 235\u2013238 (2006).","DOI":"10.1038\/nature04753"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Leppkes M, Becker C, Ivanov II, Hirth S, Wirtz S, Neufert C, Pouly S, Murphy AJ, Valenzuela DM, Yancopoulos GD, Becher B, Littman DR, Neurath MF. ROR\u03b3-expressing Th17 cells induce murine chronic intestinal inflammation via<\/i> redundant effects of IL-17A and IL-17F. Gastroenterology<\/i>, 136<\/b>, 257\u2013267 (2009).","DOI":"10.1053\/j.gastro.2008.10.018"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature<\/i>, 464<\/b>, 1371\u20131375 (2010).","DOI":"10.1038\/nature08949"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Xiao YT, Yan WH, Cao Y, Yan JK, Cai W. Neutralization of IL-6 and TNF-\u03b1 ameliorates intestinal permeability in DSS-induced colitis. Cytokine<\/i>, 83<\/b>, 189\u2013192 (2016).","DOI":"10.1016\/j.cyto.2016.04.012"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Menesy A, Hammad M, Aref S, Abozeid FAM. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity. BMC Gastroenterol.<\/i>, 24<\/b>, 135 (2024).","DOI":"10.1186\/s12876-024-03218-7"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Lucaciu LA, Ilie\u0219 M, Vesa \u0218C, Seicean R, Din S, Iuga CA, Seicean A. Serum interleukin (IL)-23 and IL-17 profile in inflammatory bowel disease (IBD) patients could differentiate between severe and non-severe disease. J. Pers. Med.<\/i>, 11<\/b>, 1130 (2021).","DOI":"10.3390\/jpm11111130"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Ding Y, Wang K, Xu C, Hao M, Li H, Ding L. Intestinal Claudin-7 deficiency impacts the intestinal microbiota in mice with colitis. BMC Gastroenterol.<\/i>, 22<\/b>, 24 (2022).","DOI":"10.1186\/s12876-022-02100-8"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol.<\/i>, 14<\/b>, 141\u2013153 (2014).","DOI":"10.1038\/nri3608"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Park JH, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, Usui Y, Hatano N, Shinohara M, Saito Y, Murata Y, Matozaki T. Promotion of intestinal epithelial cell turnover by commensal bacteria: role of short-chain fatty acids. PLOS ONE<\/i>, 11, e0156334<\/b> (<\/b>2016).","DOI":"10.1371\/journal.pone.0156334"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Fritsch J, Garces L, Quintero MA, et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol.<\/i>, 19<\/b>, 1189\u20131199.e30 (2021).","DOI":"10.1016\/j.cgh.2020.05.026"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature<\/i>, 505<\/b>, 559\u2013563 (2014).","DOI":"10.1038\/nature12820"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Tian S, Paudel D, Hao F, Neupane R, Castro R, Patterson AD, Tiwari AK, Prabhu KS, Singh V. Refined fiber inulin promotes inflammation-associated colon tumorigenesis by modulating microbial succinate production Cancer Rep. Cancer Rep.<\/i>, 6<\/b>, e1863 (2023).","DOI":"10.1002\/cnr2.1863"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Armstrong HK, Bording-Jorgensen M, Santer DM, et al. Unfermented \u03b2-fructan fibers fuel inflammation in select inflammatory bowel disease patients. Gastroenterology<\/i>, 164<\/b>, 228\u2013240 (2023).","DOI":"10.1053\/j.gastro.2022.09.034"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD Jr, Zhang L, Wang WB, Hao S, Flythe MD, Gonzalez DJ, Cani PD, Conejo-Garcia JR, Xiong N, Kennett MJ, Joe B, Patterson AD, Gewirtz AT, Vijay-Kumar M. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell<\/i>, 175<\/b>, 679\u2013694.e22 (2018).","DOI":"10.1016\/j.cell.2018.09.004"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Miles JP, Zou J, Kumar MV, Pellizzon M, Ulman E, Ricci M, Gewirtz AT, Chassaing B. Supplementation of low- and high-fat diets with fermentable fiber exacerbates severity of DSS-induced acute colitis. Inflamm. Bowel Dis.<\/i>, 23<\/b>, 1133\u20131143 (2017).","DOI":"10.1097\/MIB.0000000000001155"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Arifuzzaman M, Won TH, Li TT, Yano H, Digumarthi S, Heras AF, Zhang W, Parkhurst CN, Kashyap S, Jin WB, Putzel GG, Tsou AM, Chu C, Wei Q, Grier A, Worgall S, Guo CJ, Schroeder FC, Artis D. Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation. Nature<\/i>, 611<\/b>, 578\u2013584 (2022).","DOI":"10.1038\/s41586-022-05380-y"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: A randomised, double-blind, placebo-controlled, cross-over, re-challenge trial. J. Crohns Colitis<\/i>, 11<\/b>, 1420\u20131429 (2017).","DOI":"10.1093\/ecco-jcc\/jjx073"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Lewis JD, Sandler RS, Brotherton C, et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn\u2019s disease. Gastroenterology<\/i>, 161<\/b>, 837\u2013852.e9 (2021).","DOI":"10.1053\/j.gastro.2021.05.047"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00399\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:01:56Z","timestamp":1772856116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00399\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00399","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"b25-00399"}}